CN101690789A - Chinese medicinal preparation for treating diabetes - Google Patents
Chinese medicinal preparation for treating diabetes Download PDFInfo
- Publication number
- CN101690789A CN101690789A CN200910217723A CN200910217723A CN101690789A CN 101690789 A CN101690789 A CN 101690789A CN 200910217723 A CN200910217723 A CN 200910217723A CN 200910217723 A CN200910217723 A CN 200910217723A CN 101690789 A CN101690789 A CN 101690789A
- Authority
- CN
- China
- Prior art keywords
- radix
- fructus
- root
- diabetes
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 239000003814 drug Substances 0.000 claims abstract description 38
- 238000011282 treatment Methods 0.000 claims abstract description 20
- 241000283956 Manis Species 0.000 claims description 8
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 8
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 8
- 210000003038 endothelium Anatomy 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 13
- 230000008901 benefit Effects 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 230000001225 therapeutic effect Effects 0.000 abstract description 3
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 abstract description 2
- 229930186217 Glycolipid Natural products 0.000 abstract description 2
- 206010022489 Insulin Resistance Diseases 0.000 abstract description 2
- 210000000988 bone and bone Anatomy 0.000 abstract description 2
- 201000010099 disease Diseases 0.000 abstract description 2
- 230000004060 metabolic process Effects 0.000 abstract description 2
- 238000005728 strengthening Methods 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 4
- 241001412627 Adenophora liliifolia Species 0.000 abstract 1
- 241001127714 Amomum Species 0.000 abstract 1
- 241000605445 Anemarrhena asphodeloides Species 0.000 abstract 1
- 244000003416 Asparagus officinalis Species 0.000 abstract 1
- 235000005340 Asparagus officinalis Nutrition 0.000 abstract 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract 1
- 241001523681 Dendrobium Species 0.000 abstract 1
- 241000287828 Gallus gallus Species 0.000 abstract 1
- 235000017784 Mespilus germanica Nutrition 0.000 abstract 1
- 244000182216 Mimusops elengi Species 0.000 abstract 1
- 235000000560 Mimusops elengi Nutrition 0.000 abstract 1
- 240000002948 Ophiopogon intermedius Species 0.000 abstract 1
- 241000283966 Pholidota <mammal> Species 0.000 abstract 1
- 241000756042 Polygonatum Species 0.000 abstract 1
- 235000008737 Polygonatum biflorum Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 241000270666 Testudines Species 0.000 abstract 1
- 241000270708 Testudinidae Species 0.000 abstract 1
- 235000007837 Vangueria infausta Nutrition 0.000 abstract 1
- 230000014101 glucose homeostasis Effects 0.000 abstract 1
- 229910052602 gypsum Inorganic materials 0.000 abstract 1
- 239000010440 gypsum Substances 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 13
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 9
- 239000008103 glucose Substances 0.000 description 9
- 230000003203 everyday effect Effects 0.000 description 7
- 210000001124 body fluid Anatomy 0.000 description 6
- 239000010839 body fluid Substances 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 230000035922 thirst Effects 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 208000008960 Diabetic foot Diseases 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000001502 supplementing effect Effects 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 229940127003 anti-diabetic drug Drugs 0.000 description 2
- 239000003472 antidiabetic agent Substances 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 208000017169 kidney disease Diseases 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000010030 glucose lowering effect Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 1
- 229960003105 metformin Drugs 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a Chinese medicinal preparation for treating diabetes, which is prepared from heterophylly falsestarwort root, gypsum, Indian buead, pollen, dwarf lilyturf tuber, cochinchnese asparagus root, chicken gizzard-membrane, tortoise plastron, dendrobium, turtle shell, medlar, cinnamomvine, common macrocarpium fruit, villous amomum fruit, root of rehmannia, Chinese magnoliavine fruit, dark plum fruit, pangolin, root of straight ladybell, fragrant solomonseal rhizome, common anemarrhena rhizome, dragon's bones and oyster shell according to a conventional Chinese medicament preparation process. The preparation is a pure Chinese medicinal preparation, is used for the treatment of the diabetes and complicating diseases thereof, and has the advantages of having steady therapeutic effect, having no toxic side effect, adjusting the environment in organisms, improving the constitution, relieving the state of insulin resistance, adjusting glycolipid metabolism, strengthening glucose homeostasis and the like.
Description
Technical field
The present invention relates to the diabetes treatment of diseases, a kind of Chinese medicine preparation for the treatment of diabetes especially is provided, belong to traditional Chinese medical science pharmaceutical technology field.
Background technology
Diabetes are a kind of chronic, general, metabolic diseases that inherited genetic factors and the long-term combined effect of environmental factors are caused.This mainly is that interior absolute or relative hyposecretion of insulin of body and target tissue cell reduce insulin sensitivity, causes a series of metabolism disorder syndromes such as protein, fat, power and water Xie Zhi, wherein is outstanding feature with the hyperglycemia.
Mostly traditional treatment is merely with Western medicine or merely with Chinese medicine or mixing application.Doctor trained in Western medicine is generally based on insulin injection or antidiabetic drug, though use the Western medicine blood sugar lowering fast merely, easily repeatedly and side effect big; Simple very slow with the Chinese medicine blood sugar reducing function, and just hypoglycemic effect is arranged in a short time, but do not reach integrally-regulated purpose, cause blood glucose repeatedly.
Summary of the invention
The present invention discloses a kind of Chinese medicine preparation for the treatment of diabetes, has solved shortcomings such as existing poisonous side effect of medicine is big, drug withdrawal bounce-back.
Technical solution of the present invention is as follows: be based on the general cognition of China's Chinese medicine to the diabetes disease, with replenishing YIN and removing heat, supplementing QI and nourishing YIN, warming YANG nourishing YIN is main the treatment, selects the pure natural Chinese herbal medicine for use, by the theory of Chinese medical science prescription, through the strictness screening, combine in conjunction with the modern crafts method for making.
Chinese medicine preparation of the present invention by following raw materials by weight portion than making:
Radix Pseudostellariae 15～20g, Gypsum Fibrosum 8～10g, Poria 10～15g, Pollen Pini 15～20g, Radix Ophiopogonis 10～15g, Radix Asparagi 10～15g, Endothelium Corneum Gigeriae Galli 20～25g, Carapax et Plastrum Testudinis 20～25g, Herba Dendrobii 10～15g, Carapax Trionycis 10～15g, Fructus Lycii 15～20g, Rhizoma Dioscoreae 10～15g, Fructus Corni 15～20g, Fructus Amomi 15～20g, the Radix Rehmanniae 10～15g, Fructus Schisandrae Chinensis 10～15g, Fructus Mume 10～15g, Squama Manis 20～25g, Radix Adenophorae (Radix Glehniae) 10～15g, Rhizoma Polygonati Odorati 10～15g, Os Draconis 25～30g, Concha Ostreae 25～30g.
Preferred prescription of the present invention is as follows:
Radix Pseudostellariae 20g, Gypsum Fibrosum 10g, Poria 15g, pollen 20g, Radix Ophiopogonis 15g, Radix Asparagi 15g, Endothelium Corneum Gigeriae Galli 25g, Carapax et Plastrum Testudinis 25g, Herba Dendrobii 15g, Carapax Trionycis 15g, Fructus Lycii 20g, Rhizoma Dioscoreae 15g, Fructus Corni 20g, Fructus Amomi 20g, Radix Rehmanniae 15g, Fructus Schisandrae Chinensis 15g, Fructus Mume 15g, Squama Manis 25g, Radix Adenophorae (Radix Glehniae) 15g, Rhizoma Polygonati Odorati 15g, Os Draconis 30g, Concha Ostreae 30g.
The preparation technology of above-mentioned Chinese medicine preparation: it is stand-by that above all medicines grind 100 order smalls altogether.
Usage and dosage: every day 3 times, each 5 grams, oral.Or incapsulate each 5 oral.
Described Chinese medicine preparation is any dosage form in the pharmaceutics.
The present invention is a principle with " replenishing YIN and removing heat, supplementing QI and nourishing YIN, warming YANG nourishing YIN ", chooses that to have kidney and spleen invigorating, consolidate the Chinese medicine of keeping fit to act on be primary raw material, concocts through science and effects a permanent cure except that the source, again can blood sugar regulation, and blood fat reducing.Wherein, Radix Pseudostellariae: invigorating qi and benefiting blood, spleen invigorating is promoted the production of body fluid.Gypsum Fibrosum: analgesic, spasmolytic, antiinflammatory.Poria: promoting diuresis to eliminate damp pathogen, spleen invigorating mind calming.Pollen Pini: the QI invigorating of dispeling the wind, removing dampness.Radix Ophiopogonis, Radix Asparagi: separate tired quench the thirst, dryness of the mouth and throat.Endothelium Corneum Gigeriae Galli: heat extraction ends tired.Carapax et Plastrum Testudinis, Carapax Trionycis, Os Draconis, Concha Ostreae: YIN nourishing, YANG hyperactivity suppressing, the kidney invigorating, strong bone.Herba Dendrobii: reinforcing stomach reg fluid, nourishing YIN and clearing away heat.Be used for cloudy impairment of body fluid and lose the xerostomia excessive thirst.Fructus Lycii: invigorating the liver and kidney, benefiting essence-blood.Rhizoma Dioscoreae: quench one's thirst.Fructus Corni: liver and kidney tonifying, essence astringing and desertion stemming.Being used for interior-heat quenches one's thirst.Fructus Amomi: acrid in the mouth, warm in nature, gas alleviating distention in middle-JIAO, invigorating the stomach and promoting digestion.The Radix Rehmanniae: clearing away heat and cooling blood, YIN nourishing and the production of body fluid promoting.Fructus Schisandrae Chinensis: restrain astringent or styptic treatment for spontaneous sweating, supplementing QI for promoting the production of body fluid, the effect that kidney calming is calmed the nerves.Fructus Mume: astringe the lung, astringing intestine to stop diarrhea promotes the production of body fluid.Being used for deficiency-heat quenches one's thirst.Squama Manis: return liver, stomach warp.Rhizoma Polygonati Odorati: only quench one's thirst the profit cardiopulmonary.Radix Adenophorae (Radix Glehniae): nourishing YIN and moistening the lung, reinforcing stomach reg fluid, Tianjin wound is thirsty.The collaborative compatibility of all medicines is formed compound recipe, the invigorating the spleen to benefit the lung of building together, and promoting the production of body fluid to quench thirst, the body resistance strengthening and constitution consolidating, the function of regulating internal organs increases immunity of organisms, reaches the effect of treatment diabetes.Can mend first deficiency entirely, also mend the deficiency of back, tonify without causing stagnation, warm and not dry, given prominence to the rule of treatment of tonifying speen and tonifying kidney, reach blood sugar regulation, the purpose of blood fat reducing.
Good effect of the present invention is: adopt the pure natural material component, scientific formulation, anxious not dry, tonification is proper, safety, no toxicity, aspect clinical observation on the therapeutic effect, raw materials used treatment determined curative effect, contrast other blood sugar lowering, fat-reducing medicament has characteristics easy to use, that bioavailability is high, is the health product of accepting for extensive patients clinically.
Good effect of the present invention is: makes preparation by pure Chinese medicine, is used for the treatment of diabetes and complication thereof, and effective in cure stable, the poison pair is done little, regulates organismic internal environment, improves body constitution, alleviate the insulin resistant state, regulate glycolipid metabolism, strengthen sugar from advantage such as steady.
For showing the therapeutic effect of medicine of the present invention, enumerate the patient of following diabetes, use medicine of the present invention to treat, the result is as follows:
Case 1
The Wang, the man, 48 years old, the main suit was thirsty, polydipsia, weak 4 years are surplus, looks into fasting glucose 9.4mmol/L, glucose in urine +++be diagnosed as " diabetes ", it is undesirable to take effect through Chinese medicine and western medicine over 3 years, and period in a medicine blood glucose drops to about 7.85mol/L, and drug withdrawal promptly rebounds. cause blurred vision, numbness of hands and feet, complication such as skin pruritus.This Chinese medicine of taking medicine, every day 3 times, each 5 grams, fasting glucose is reduced to 5.3mol/L after January, and glucose in urine is normal.Drug withdrawal after taking 4 courses of treatment, hematuria sugar is all normal.
Case 2
Liu, the woman suffered from diabetic history nearly ten years in 55 years old, with the Western medicine glucose-lowering treatment, because the control that is not careful in one's diet at ordinary times, state of an illness control is not good for a long time, and concurrent diabetic foot, the necrosis of left foot toe is now taken diabetes pill, metformin etc. and can not be controlled blood sugar increasing, the state of an illness repeatedly, looking into fasting glucose is 9.48mmoi/l, and diabetic foot is serious, and lower limb pain is arranged.The patient takes this Chinese medicine, every day 3 times, and each 5 grams, after two courses of treatment, after two months, fasting glucose is reduced to 5.8mmoi/l, and the mental status is good, and diabetic foot partly heals, and has a pain in the leg to alleviate.Continue to treat five courses of treatment so far, state of an illness control is satisfied, and blood glucose is within normal range, and diabetes are almost recovered, and existing the continuation treated.
Case 3
Liao, the man 51 years old, suffered from diabetes 8 years, once took various antidiabetic drug treatments, poor effect, the state of an illness are serious day by day, concurrent coronary heart disease, nephropathy, numb twinge, have to adopt insulinize, long-acting, middle effect, fugitive, effect are not clearly, take this Chinese medicine through cooperation, every day 3 times, each 5 grams, " three-many-one-little " obviously disappears, and after the course of treatment, coronary heart disease, nephropathy, symptom obviously reduce, numb twinge complete obiteration is fully recovered drug withdrawal now after continuing to strengthen two courses of treatment again.Follow up a case by regular visits to so far no abnormality seen.
The specific embodiment:
By following examples the present invention is described for example further, and do not limit the present invention in any way, under the prerequisite that does not deviate from technical solution of the present invention, any change or change that those of ordinary skills that the present invention did are realized easily all will fall within the claim scope of the present invention.
Embodiment 1
Take by weighing medicine: Radix Pseudostellariae 20g, Gypsum Fibrosum 10g, Poria 15g, Pollen Pini 20g, Radix Ophiopogonis 15g, Radix Asparagi 15g, Endothelium Corneum Gigeriae Galli 25g, Carapax et Plastrum Testudinis 25g, Herba Dendrobii 15g, Carapax Trionycis 15g, Fructus Lycii 20g, Rhizoma Dioscoreae 15g, Fructus Corni 20g, Fructus Amomi 20g, Radix Rehmanniae 15g, Fructus Schisandrae Chinensis 15g, Fructus Mume 15g, Squama Manis 25g, Radix Adenophorae (Radix Glehniae) 15g, Rhizoma Polygonati Odorati 15g, Os Draconis 30g, Concha Ostreae 30g.
More than all medicines grind 100 order smalls altogether, every day 3 times, each 5 the gram, oral.
Embodiment 2
Take by weighing medicine: Radix Pseudostellariae 15g, Gypsum Fibrosum 8g, Poria 15g, Pollen Pini 18g, Radix Ophiopogonis 10g, Radix Asparagi 15g, Endothelium Corneum Gigeriae Galli 22g, Carapax et Plastrum Testudinis 22g, Herba Dendrobii 10g, Carapax Trionycis 10g, Fructus Lycii 15g, Rhizoma Dioscoreae 15g, Fructus Corni 18g, Fructus Amomi 18g, Radix Rehmanniae 10g, Fructus Schisandrae Chinensis 10g, Fructus Mume 10g, Squama Manis 20g, Radix Adenophorae (Radix Glehniae) 10g, Rhizoma Polygonati Odorati 10g, Os Draconis 25g, Concha Ostreae 25g.
More than all medicines grind 100 order smalls altogether, every day 3 times, each 5 the gram, oral.
Embodiment 3
Take by weighing medicine: Radix Pseudostellariae 18g, Gypsum Fibrosum 10g, Poria 10g, Pollen Pini 15g, Radix Ophiopogonis 15g, Radix Asparagi 15g, Endothelium Corneum Gigeriae Galli 20g, Carapax et Plastrum Testudinis 205g, Herba Dendrobii 15g, Carapax Trionycis 15g, Fructus Lycii 20g, Rhizoma Dioscoreae 10g, Fructus Corni 15g, Fructus Amomi 15g, Radix Rehmanniae 15g, Fructus Schisandrae Chinensis 15g, Fructus Mume 15g, Squama Manis 20g, Radix Adenophorae (Radix Glehniae) 15g, Rhizoma Polygonati Odorati 15g, Os Draconis 30g, Concha Ostreae 30g.
More than all medicines grind 100 order smalls altogether, every day 3 times, each 5 the gram, oral.
Claims (3)
1. Chinese medicine preparation for the treatment of diabetes, by following raw materials by weight portion than making:
Radix Pseudostellariae 15～20g, Gypsum Fibrosum 8～10g, Poria 10～15g, Pollen Pini 15～20g, Radix Ophiopogonis 10～15g, Radix Asparagi 10～15g, Endothelium Corneum Gigeriae Galli 20～25g, Carapax et Plastrum Testudinis 20～25g, Herba Dendrobii 10～15g, Carapax Trionycis 10～15g, Fructus Lycii 15～20g, Rhizoma Dioscoreae 10～15g, Fructus Corni 15～20g, Fructus Amomi 15～20g, the Radix Rehmanniae 10～15g, Fructus Schisandrae Chinensis 10～15g, Fructus Mume 10～15g, Squama Manis 20～25g, Radix Adenophorae (Radix Glehniae) 10～15g, Rhizoma Polygonati Odorati 10～15g, Os Draconis 25～30g, Concha Ostreae 25～30g.
2. the described Chinese medicine preparation of claim 1 is characterized in that:
Radix Pseudostellariae 20g, Gypsum Fibrosum 10g, Poria 15g, Pollen Pini 20g, Radix Ophiopogonis 15g, Radix Asparagi 15g, Endothelium Corneum Gigeriae Galli 25g, Carapax et Plastrum Testudinis 25g, Herba Dendrobii 15g, Carapax Trionycis 15g, Fructus Lycii 20g, Rhizoma Dioscoreae 15g, Fructus Corni 20g, Fructus Amomi 20g, Radix Rehmanniae 15g, Fructus Schisandrae Chinensis 15g, Fructus Mume 15g, Squama Manis 25g, Radix Adenophorae (Radix Glehniae) 15g, Rhizoma Polygonati Odorati 15g, Os Draconis 30g, Concha Ostreae 30g.
3. claim 1 or 2 described Chinese medicine preparation are any dosage form in the pharmaceutics.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102177236A CN101690789B (en) | 2009-09-29 | 2009-09-29 | Chinese medicinal preparation for treating diabetes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102177236A CN101690789B (en) | 2009-09-29 | 2009-09-29 | Chinese medicinal preparation for treating diabetes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101690789A true CN101690789A (en) | 2010-04-07 |
| CN101690789B CN101690789B (en) | 2011-07-20 |
Family
ID=42079538
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009102177236A Expired - Fee Related CN101690789B (en) | 2009-09-29 | 2009-09-29 | Chinese medicinal preparation for treating diabetes |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101690789B (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101953948A (en) * | 2010-09-19 | 2011-01-26 | 李小杵 | Medicine used for curing diabetes of deficiency of Qi-Yin syndrome |
| CN103768294A (en) * | 2013-10-12 | 2014-05-07 | 秦洪涛 | Medical application of colocasia tonoimo nakia and stem leaves thereof in preventing and treating diabetes |
| CN103816428A (en) * | 2014-03-26 | 2014-05-28 | 李常明 | Preparation for effectively treating diabetes mellitus |
| CN104758316A (en) * | 2015-04-24 | 2015-07-08 | 宁波大学 | Pharmaceutical composition for preventing and curing diabetes itches |
| CN106177479A (en) * | 2015-04-29 | 2016-12-07 | 无限极（中国）有限公司 | A kind of Hyperglycemic health care compositions comprising Herba Dendrobii and Rhizoma Polygonati Odorati |
| CN106377695A (en) * | 2016-11-15 | 2017-02-08 | 河南中医药大学 | Traditional Chinese medicine composition capable of reducing blood sugar |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1189358A (en) * | 1997-01-31 | 1998-08-05 | 赵清涛 | Chinese medicinal tea for reducing sugar and eliminating thirst and prodn. method |
| CN1331514C (en) * | 2005-11-11 | 2007-08-15 | 李永红 | Capsnle for treating type II diabetes |
-
2009
- 2009-09-29 CN CN2009102177236A patent/CN101690789B/en not_active Expired - Fee Related
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101953948A (en) * | 2010-09-19 | 2011-01-26 | 李小杵 | Medicine used for curing diabetes of deficiency of Qi-Yin syndrome |
| CN101953948B (en) * | 2010-09-19 | 2012-05-09 | 李小杵 | Medicine for treating qi-yin deficiency type diabetes |
| CN103768294A (en) * | 2013-10-12 | 2014-05-07 | 秦洪涛 | Medical application of colocasia tonoimo nakia and stem leaves thereof in preventing and treating diabetes |
| CN103816428A (en) * | 2014-03-26 | 2014-05-28 | 李常明 | Preparation for effectively treating diabetes mellitus |
| CN103816428B (en) * | 2014-03-26 | 2016-03-02 | 青岛大学附属医院 | A kind of preparation of effective treatment diabetes |
| CN104758316A (en) * | 2015-04-24 | 2015-07-08 | 宁波大学 | Pharmaceutical composition for preventing and curing diabetes itches |
| CN106177479A (en) * | 2015-04-29 | 2016-12-07 | 无限极（中国）有限公司 | A kind of Hyperglycemic health care compositions comprising Herba Dendrobii and Rhizoma Polygonati Odorati |
| CN106377695A (en) * | 2016-11-15 | 2017-02-08 | 河南中医药大学 | Traditional Chinese medicine composition capable of reducing blood sugar |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101690789B (en) | 2011-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1723926A (en) | Traditional Chinese medicine liquor and preparation method thereof | |
| CN101690789B (en) | Chinese medicinal preparation for treating diabetes | |
| CN100509025C (en) | A medicine for treating diabetes | |
| CN103007159B (en) | Chinese medicinal preparation for correcting pancreas islet function | |
| CN102886019A (en) | Traditional Chinese medicinal blood sugar reducing plaster | |
| CN102327436A (en) | Traditional Chinese medicine composition for treating edema during menstruation | |
| CN102125645B (en) | Traditional Chinese medicine preparation for treating osteoporosis | |
| CN103751558B (en) | A kind of compound antihypelipidemic pill and preparation method thereof | |
| CN100455317C (en) | Medicament for treating type 2 diabetes | |
| CN101850071A (en) | Chinese medicament for treating chronic nephritis | |
| CN101491651A (en) | Medicine for treating diabetes | |
| CN105796755A (en) | Traditional Chinese medicinal composition for treating diabetic nephropathy | |
| CN100398143C (en) | Medicament for treating vitiligo | |
| CN102380017A (en) | Medicament for treating diabetes and preparation method of medicament | |
| CN108295215A (en) | A kind of Chinese medicine preparation and preparation method for treating the left paralysis and right paralysis of body after apoplexy | |
| CN102068583B (en) | Chinese medicinal preparation for treating preceded menstrual cycle due to deficiency of vital energy | |
| CN102631618A (en) | Traditional Chinese medicine for treating diabetes | |
| CN101983688B (en) | Drug for treating diabetes and preparation method thereof | |
| CN101721593A (en) | Medicinal and edible biological composition for improving diabetes and preparation method of capsule thereof | |
| CN104758889A (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN100369621C (en) | Medicine for treating diabetes | |
| CN106266427A (en) | A kind of Traditional Chinese medicinal liquor treating nephropathy and preparation method thereof | |
| CN106668390B (en) | Traditional Chinese medicine composition for treating hyperthyroidism in early and middle stages | |
| CN106039028A (en) | Blood-glucose reducing pill and preparation method thereof | |
| CN1317014C (en) | Soaking bath Chinese medicine for treating diabetes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110720 Termination date: 20120929 |